Nicholas L. Reed

Nicholas L. Reed

Auto-generated profile, based on publicly available information

Nicholas L. Reed

US Process Chemistry, CMC Synthetics Platform, Sanofi, 350 Water Street, Cambridge, Massachusetts 02141, United States

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 November 2021 in Chemical Reviews
Verified
Journal Article
Closed access
ACAmy Y. Chan
Amy Y. Chan
IPIan B. Perry
Ian B. Perry
NBNoah B. Bissonnette
Noah B. Bissonnette
BBBenito F. Buksh
Benito F. Buksh
GEGrant A. Edwards
Grant A. Edwards
DMDavid W. C. MacMillan
David W. C. MacMillan

25 January 2021 in Chemical Society Reviews
Verified
Journal Article
Closed access
PDF file
NRNicholas L. Reed
Nicholas L. Reed
TYTehshik P. Yoon
Tehshik P. Yoon
This tutorial review highlights the distinctive mechanistic roles of and practical considerations regarding terminal oxidants in photocatalytic “oxidase”-type reactions.

15 April 2021 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
NRNicholas L. Reed
Nicholas L. Reed
GLGrace A. Lutovsky
Grace A. Lutovsky
TYTehshik P. Yoon
Tehshik P. Yoon

8 November 2018 in Organic Letters
Verified
Journal Article
Closed access
NRNicholas L. Reed
Nicholas L. Reed
MHMadeline I. Herman
Madeline I. Herman
VMVladimir P. Miltchev
Vladimir P. Miltchev
TYTehshik P. Yoon
Tehshik P. Yoon

1 June 2016 in Molecular Pharmacology
Verified
Journal Article
Closed access
PDF file
MKManoj Kumar
Manoj Kumar
NRNicholas Reed
Nicholas Reed
RLRuiting Liu
Ruiting Liu
EAElias Aizenman
Elias Aizenman
PWPeter Wipf
Peter Wipf
TTThanos Tzounopoulos
Thanos Tzounopoulos
KQT-like subfamily (KCNQ) channels are voltage-gated, noninactivating potassium ion channels, and their down-regulation has been implicated in several hyperexcitability-related disorders, including epilepsy, neuropathic pain, and tinnitus. Activators of these channels reduce the excitability of central and peripheral neurons, and, as such, have therapeutic utility. Here, we synthetically modified several moieties of the KCNQ2–5 channel activator retigabine, an anticonvulsant approved by the U.S. Food and Drug Administration. By introducing a CF3–group at the 4-position of the benzylamine moiety, combined with a fluorine atom at the 3-position of the aniline ring, we generated Ethyl (2-amino-3-fluoro-4-((4-(trifluoromethyl)benzyl)amino)phenyl)carbamate (RL648_81), a new KCNQ2/3-specific activator that is >15 times more potent and also more selective than retigabine. We suggest that RL648_81 is a promising clinical candidate for treating or preventing neurologic disorders associated with neuronal hyperexcitability.

5 February 2019 in Beilstein Journal of Organic Chemistry
Verified
Journal Article
Open access
PDF file
NRNicholas L Reed
Nicholas L Reed
MHMadeline I Herman
Madeline I Herman
VMVladimir P Miltchev
Vladimir P Miltchev
TYTehshik P Yoon
Tehshik P Yoon
Oxidative alkene difunctionalization reactions are important in synthetic organic chemistry because they can install polar functional groups onto simple non-polar alkene moieties. Many of the most common methods for these reactions rely upon the reactivity of pre-oxidized electrophilic heteroatom donors that can often be unstable, explosive, or difficult to handle. Herein, we describe a method for alkene oxyamination and diamination that utilizes simple carbamate and urea groups as nucleophilic heteroatom donors. This method uses a tandem copper–photoredox catalyst system that is operationally convenient. The identity of the terminal oxidant is critical in these studies. Ag(I) salts proved to be unique in their ability to turn over the copper cocatalyst without deleteriously impacting the reactivity of the organoradical intermediates.